Oramed Pharmaceuticals (ORMP) Receivables - Other (2011 - 2023)
Oramed Pharmaceuticals (ORMP) posted Receivables - Other of $3.2 million for Q2 2023, up 3031.07% on a QoQ basis from $103000.0 in Q1 2023, and up 3424.74% year-over-year from $91496.1 in Q2 2022.
Oramed Pharmaceuticals (ORMP) Receivables - Other (2011 - 2023) Analysis & Trends
Oramed Pharmaceuticals' Receivables - Other history runs 9 years deep, the most recent figure standing at $3.2 million for Q2 2023.
- Quarterly Receivables - Other rose 3424.74% year-over-year to $3.2 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $2.6 million (up 183.02% YoY) and the FY2022 annual result came in at $376000.0, up 154.57% from the prior year.
- Receivables - Other was $3.2 million for Q2 2023 at Oramed Pharmaceuticals, up from $103000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $3.2 million in Q2 2023 and bottomed at -$3.3 million in Q3 2021.
- A 4-year average of -$54583.3 and a median of -$25500.0 in 2022 frame the typical range for Receivables - Other.
- Peak annual rise in Receivables - Other reached 3424.74% in 2023, while the deepest fall reached 91.05% in 2023.
- Oramed Pharmaceuticals' Receivables - Other stood at -$1.2 million in 2020, then rose by 14.92% to -$981000.0 in 2021, then jumped by 104.69% to $46000.0 in 2022, then surged by 6910.87% to $3.2 million in 2023.
- Business Quant data shows ORMP's Receivables - Other at $3.2 million in Q2 2023, $103000.0 in Q1 2023, and $46000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3.23 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2023 | 103,000.00 |
| Mar 31, 2023 | 103,000.00 |
| Dec 31, 2022 | 46,000.00 |
| Dec 31, 2022 | 46,000.00 |
| Sep 30, 2022 | -724,000.00 |
| Sep 30, 2022 | -724,000.00 |
| Jun 30, 2022 | -97,000.00 |
| Jun 30, 2022 | -97,000.00 |
| Mar 31, 2022 | 1.15 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Nov 30, 2021 | -981,000.00 |
| Nov 30, 2021 | -981,000.00 |
| Aug 31, 2021 | -3.27 Mn |
| Aug 31, 2021 | -3.27 Mn |
| May 31, 2021 | 172,000.00 |
| May 31, 2021 | 172,000.00 |
| Feb 28, 2021 | -151,000.00 |
| Feb 28, 2021 | -151,000.00 |